Anorganic bone mineral coated with tetra-cell adhesion molecule enhances the activation of osteoblast-like cells

Tissue Engineering and Regenerative Medicine

Volumn 5, Issue 4-6, 2008, Pages 811-820

  Park, Jin Woo ^a   Kang, Seung Hoon ^a   Yeo, Shin il ^a   Kim, In San ^b   Bae, Yong Chul ^c   Suh, Jo Young ^a,d  

^a School of Dentistry   (South Korea)

^b Department of Obstetrics and Gynecology   (South Korea)

^c Department of Oral Microbiology and Immunology   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

Bone mineral; Osteoblast like cell; Tetra cell adhesion molecule

Indexed keywords

ADHESION MOLECULES; ANORGANIC BONE MINERALS; ARGININE-GLYCINE-ASPARTIC ACIDS; BIOMIMETIC ENVIRONMENT; BONE MINERALS; CELL-ADHESIVE PROTEINS; INTERCELLULAR BRIDGES; OSTEOBLAST-LIKE CELLS;

ARGININE; BINDING ENERGY; BIOMIMETICS; BIOMOLECULES; BIOSYNTHESIS; BONE; CELL ADHESION; CELL CULTURE; CELLS; DEFECTS; MINERALS; TISSUE ENGINEERING;

CAMS;

EID: 84884551427     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. JP Vacanti, R Langer, Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation, Lancet, 354, 32 (1999).
2. G Khang, SH Kim, MS Kim, et al., Recent and future directions of stem cells for the application of regenerative medicine, Tissue Eng Regen Med, 4(4), 441 (2007).
3. CA Heath, Cells for engineering, TIBTECH, 18, 17 (2000).
4. KN Yamada, Fibronectin and other cell interactive glucoproteins. In: HAYED(ed.) Cell Biology of Extracellular Matrix, New York: Plenum Press, 111 (1991).
5. E Ruoslahti, Fibronectin and its receptors, Annu Rev Biochem, 57, 375 (1988).
6. MD Pierschbacher, E Ruoslahti, Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule, Nature, 309, 30 (1984).
7. KM Yamada, DW Kennedy, Dualistic nature of adhesive protein function: Fibronectin and its biologically active peptide fragments can auto inhibit fibronectin function, J Cell Biol, 99, 29 (1984).
8. A Hautanen, J Gailit, DM Mann, et al., Effects of modifications of the RGD sequence and its context on recognition by the fibronectin receptor, J Biol Chem, 264, 1437 (1989).
9. M Obara, MS Knag, KM Yamada, Site-directed mutagenesis of the cell-binding domain of fibronectin: Separable, synergistic sites mediate adhesive function, Cell, 53, 649 (1988).
10. R Pytela, MD Pierschbacher, E Ruoslahti, Identification and isolation of a140 kD cell surface glycoprotein with properties expected of a fibronectin receptor, Cell, 40, 191 (1985)
11. E Ruoslahti, MD Pierschacher, New perspectives in cell adhesion: RGD and integrins, Science, 238, 291 (1987).
12. AM Mardon, KE Grant, The role of the ninth and tenth type III domains of human fibronectin in cell adhesion, FEBS Lett, 340, 197 (1994).
13. J Skonier, K Bennett, V Rothwell, et al., ßig-h3: a transforming growth factor beta-responsive gene encoding asecreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice, DNA Cell Biol, 13, 571 (1994).
14. T Kawamoto, M Noshiro, M Shen, et al., Structural and phylogenetic analyses of RGD-CA P/ßig-h3, a fasciclin-like adhesion protein expressed in chick chondrocytes, Biochim Biophys Acta, 1395, 288 (1998).
15. J Skonier, M Noshiro, L Madisen, et al., cDNA cloning and sequence analysis of ßig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-ß, DNA Cell Biol, 7, 511 (1992).
16. JE Kim, EH Kim, EH Han, et al., A TGF-ß-inducible cell adhesion molecule, ßig-h3, is down regulated in melorheostosis and involved in osteogenesis, J Cell Biochem, 77, 169 (2000).
17. JE Kim, HW Joeng, JO Nam, et al., Identification of motifs in the fasciclin domains of the transforming growth factor-ß-induced matrix protein ßig-h3 that interact with the avß5integrin, J Biol Chem, 29, 46159 (2002).
18. S Keila, S Pitaru, A Grosskopf, et al., Bone marrow from mechanically unloaded rat bones expresses reduced osteogenic capacity in vitro, J Bone Miner Res, 9, 321 (1994).
19. PV Bodine, J Green, HA Harris, et al., Functional properties of a conditionally phenotypic, estrogen-responsive, human osteoblast cell line, J Cell Biochem, 65, 368 (1997).
20. CM Stanford, PA Jacobson, ED Eanes, et al., Rapidly forming apatitic mineral in an osteoblastic cell line(UMR 106-01 BSP), J Biol Chem, 270, 9420 (1995).
21. RO Hynes, Fibronectins, Springer-Verlag, New York, 546 (1990
22. HS Jang, JS Rim, ES Lee, et al., Influence of fibronectin, type 1 collagen and vitronectin on migration of osteoblast, Tissue Eng Regen Med, 1(2), 190 (2004).
23. RD Bowditch, M Hariharan, EF Tominna, et al., Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins, J Biol Chem, 269, 10856 (1994).
24. SC Dieudonne, KM Kerr, T Xu, et al., Differential display of human marrow stromal cells reveals unique mRNA expression patterns in response to dexamethasone, J Cell Biochem, 76, 231 (1999).
25. IM Rawe, Q Zhan, R Burrows, et al., Molecular cloning and in situ hybridization in corneal tissues, Invest Ophthalmo & Visual Sci, 38, 893 (1997).
26. WW Lee, JS Park, HJ Do, et al, Inducement of chondrogenic differentiation in injectable hydrogels embedded in mouse embryonic stem cells and growth factor for neocartilage formation, Tissue Eng Regen Med, 5(1), 103 (2008).
27. S Ohno, M Noshiro, S Makihira, et al., YRGD-CAP((beta)ig-h3) enhances the spreading of chondrocytes and fibroblasts via integrinalpha(1) beta(1), Biochim Biophys Acta, 1451, 196 (1999).
28. JY Choi, BH Lee, KB Song, et al., Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells, J Cell Biochem, 61, 609 (1996).
29. Z Schwartz, T Weesner, DS Van, et al., Ability of deproteinized cancellous bovine bone to induce new bone formation, J Periodontol, 71, 1258 (2000).
30. TI Kim, JH Jang, CP Chung, et al., Fibronectin fragment promotes osteoblast-associated gene expression and biological activity of human osteoblast-like cell, Biotech Lett, 25, 2007 (2003).
31. YI Yang, HI Kim, JY Seo, et al., Adult stem cells as cell therapeutics for angiogenesis, Tissue Eng Regen Med, 4(4), 484 (2007).
32. S Iseki, AO Wilkie, JK Heath, et al., Fgfr 2 and osteopontin domains in the developing skull vault are mutually exclusive applied FGF2, Develoment, 124, 3375 (1997).
33. S Iseki, AO Wilkie, GM Morris-Kay, Fgfr 1 and Fgfr 2 have distinct differentiation and proliferation-related roles in the developing mouse skull vault, Development, 126, 5611 (1999).
34. MH Park, HI Shin, JY Choi, et al., Differential expression patterns of Runx2 isoforms in cranial suture morphogenesis, J Bone Miner Res, 16, 885 (2001).
35. T Kubota, M Yamauchi, J Onozaki, et al., Influence of an intermittent compressive force on matrix protein expression by ROS 17/2.8 cells, with selective stimulation of osteopontin, Arch Oral Biol, 38, 23 (1993).
36. J Klein-Nulend, J Roelofsen, CM Semeins, et al., Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures, J Cell Physiol, 170, 174 (1997).
37. J Klein-Nulend, CM Semeins, JP Veldhuijzen, et al., Effect of mechanical stimulation on the production of soluble bone factors in cultured fetal mouse calvariae, Cell Tissue Res, 271, 513 (1993).
38. I Owan, D Burr, C Turner, et al., Mechanotransduction in bone: osteoblasts are more responsive to fluid forces than mechanicalstrain, Am J Physiol, 273, 810 (1997).
39. GN Bancroft, VI Sikavitsas, J van den Dolder, et al., Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner, Proc Natl Acad Sci USA, 99, 12600 (2002).
40. RS Carvalho, A Bumann, JL Schaer, et al., Predominant integrin ligands expressed by osteoblasts show preferential regulation inresponse to both cell adhesion and mechanical perturbation, J Cell Biochem, 84, 497 (2002).
41. KM Choi, YK Seo, HH Yoon, et al., Differentiation of human bone marrow-derived mesenchymal stem cell into fibroblast-like cell in vitro by mechanical tension, Tissue Eng Regen Med, 3(4), 423 (2006).
42. J Clover, RA Dodds, M Gowen, Integrin subunit expression by human osteoblasts and osteoclasts in situ and in culture, J Cell Sci, 103, 267 (1992).
43. K Hultenby, FP Reinholt, D Heinegard, Distribution of integrin subunits on rat metaphyseal osteoclasts and osteoblasts, Eur J Cell Biol, 62, 86 (1993).
44. EK Lee, JS Lee, HS Park, et al., Stretch-stimulated cellular rearrangement and alteration of fibronectin matrix assembly, a-smooth muscle actin, and CD44 expression in human mesenchymal stem cells, Tissue Eng Regen Med, 2(2), 94 (2005).
45. CT Brighton, SM Albelda, Identification of integrin cell substratum adhesion receptors on cultured rat bone cells, J Orthop Res, 10, 766 (1992).
46. A Krammer, D Craig, WE Thomas, et al., A structural model for force regulated integrin binding to fibronectin's RGD-synergysite, Matrix Biol, 21, 139 (2002).